Physician

Reju M. George, MD

According to 2025 Medicare claims, Reju George, MD (NPI: 1184041139) practices medical oncology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Albany, NY. This provider's primary affiliated billing organization is NEW YORK ONCOLOGY HEMATOLOGY, P.C. (NPI: 1609863448; TIN: 141799724) and primary practice location at 12208-3412.

George's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 459 traditional Medicare patients, billed 48,993 HCPCS/CPT codes, and received $1,051,506 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,075 prescription claims across 139 beneficiaries totaling $2,925,761 in drug costs, led by Revlimid (Lenalidomide). 2016 DME data shows 16 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $72,436 to $1,051,506. Similarly, Part D prescription costs have moved sharply higher in recent years, from $25,116 to $2,925,761. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$526K$1.1M2020 Medicare payment: $72,436 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $575,386 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $599,448 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $901,723 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,051,506 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020903,391$72,436
202134429,146$575,386
202240040,397$599,448
202344459,337$901,723
202445948,993$1,051,506

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$2.9M2015 Drug cost: $25,116 (USD; Tot_Drug_Cst)2016 Drug cost: $28,640 (USD; Tot_Drug_Cst)2017 Drug cost: $27,707 (USD; Tot_Drug_Cst)2018 Drug cost: $5,310 (USD; Tot_Drug_Cst)2019 Drug cost: $9,722 (USD; Tot_Drug_Cst)2020 Drug cost: $62,854 (USD; Tot_Drug_Cst)2021 Drug cost: $1,413,400 (USD; Tot_Drug_Cst)2022 Drug cost: $2,752,247 (USD; Tot_Drug_Cst)2023 Drug cost: $2,424,555 (USD; Tot_Drug_Cst)2024 Drug cost: $2,925,761 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201569418$25,116
201676551$28,640
201781543$27,707
201836116$5,310
20193292$9,722
202047122$62,854
202178454$1,413,400
2022132886$2,752,247
20231501,148$2,424,555
20241391,075$2,925,761

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$115$2302016 Medicare payment: $230 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R16$230
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more156284$88
80053Blood test, comprehensive group of blood chemicals267586$10
36415Insertion of needle into vein for collection of blood sample287691$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count284652$8
83615Lactate dehydrogenase (enzyme) level162294$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide28784$536,646
JakafiRuxolitinib Phosphate30900$504,792
LenalidomideLenalidomide371,036$444,618
ImbruvicaIbrutinib19541$329,905
CalquenceAcalabrutinib Maleate17510$255,085

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Reju M. George, MD?

Tedicare shows public-source Medicare data for Reju M. George, MD (NPI 1184041139), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Reju M. George, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Reju M. George, MD?

Reju M. George, MD is linked to NEW YORK ONCOLOGY HEMATOLOGY, P.C. (billing NPI 1609863448) in the available physician profile data.

Does Reju M. George, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.